

RBS: Credit Suisse reiterates underperform and 320p target. GlaxoSmithKline: Deutsche reiterates hold and lowers target to 1,540p from 1,600p. HSBC: ...


** Engineer Bodycote boosted as Citi upgrades rating on stock to "buy" ** Citi sees current share price as good entry point (stock down c.8 pct from e...